ベンゾジアゼピン薬の世界市場 - 製品別・用途別・投与経路別・流通チャネル別・地域別：市場規模・シェア・将来展望・機会分析 (2022年～2030年)

ベンゾジアゼピン薬は、神経系に鎮静/催眠作用をもたらす、処方箋のみの薬剤のグループです。現在、市場参入企業が製品ポートフォリオの拡充のため、製造施設の拡大に取り組んでおり、それが今後の成長促進につながると考えられています。また、規制当局から承認の取得も予測期間中の市場を促すものと思われます。

当レポートでは、世界のベンゾジアゼピン薬の市場について分析し、製品の概要や、市場の基本構造および促進・抑制要因、新型コロナウイルス感染症 (COVID-19) の影響、製品別・用途別・投与経路別・流通チャネル別・地域別の市場動向の見通し、主要企業のプロファイル・薬剤ポートフォリオなどを調査しております。

目次

第1章 分析目的・前提条件

第2章 市場概略

• 分析概要
  • 市場の定義と範囲
• エグゼクティブサマリー
• COM (Coherent Opportunity Map)

第3章 市場の力学・規制・動向の分析

• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
• 影響分析
• 規制シナリオ
• PEST分析
• 昨今の製品上市／承認
• 疫学
• 企業合併・買収 (M&A)

第4章 新型コロナウイルス感染症 (COVID-19) の影響分析

• サプライチェーンへの影響
• 研究開発への影響
• 政府のイニシアチブ

第5章 世界のベンゾジアゼピン薬市場：製品別 (単位：100万米ドル、2017年～2030年)

• イントロダクション
• 長時間作用型ベンゾジアゼピン
• 短時間作用型ベンゾジアゼピン

第6章 世界のベンゾジアゼピン薬市場：用途別 (単位：100万米ドル、2017年～2030年)

• イントロダクション
• 不安障害
• 緊張感
• 鎮静
• 発作
• アルコール離脱
• その他

第7章 世界のベンゾジアゼピン薬市場：投与経路別 (単位：100万米ドル、2017年～2030年)

• イントロダクション
• 経口薬
• 注射剤
• その他

第8章 世界のベンゾジアゼピン薬市場：流通チャネル別 (単位：100万米ドル、2017年～2030年)

• イントロダクション
• 病院薬局
• 小売薬局
• オンライン薬局

第9章 世界のベンゾジアゼピン薬市場：地域別 (単位：100万米ドル、2017年～2030年)

• イントロダクション
• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第10章 競合情勢

• 企業プロファイル
  • F.Hoffmann-La Roche Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Mallinckrodt Pharmaceuticals
  • Pfizer Inc.
  • Viatris Inc.(Mylan NV)
  • Labiana Pharmaceuticals
  • Bausch Health Companies, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Amneal Pharmaceuticals LLC
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Par Pharmaceutical
  • Intas Pharmaceuticals Ltd.
• アナリストの見解

第11章 付録

Benzodiazepines are a group of prescription-only medicines that have a sedating/hypnotic and calming effects on the nervous system. Some of the examples of benzodiazepines that are used for the treatment of anxiety, seizures, etc. are diazepam, lorazepam, oxazepam, temazepam, and alprazolam. Most of the benzodiazepine drugs are available as generics as most of the patent are expired. The benzodiazepine are still widely recognizable under brand names such as Valium or Xanax. They come in the form of tablet and capsule forms and some are available for intravenous forms to be used in hospital settings.

Market Dynamics

Market players are engaged in facility expansion, in order to expand its manufacturing facility and product portfolio. This is expected to drive growth of the global benzodiazepine drugs market over the forecast period. For instance, in January 2018, Torrent Pharmaceuticals Ltd. acquired Bio-Pharm, Inc., a U.S.-based generic pharmaceuticals and over-the-counter (OTC) Company which also included a U.S. Food and Drug Administration (FDA) registered 75,000 sqft manufacturing facility in the U.S.

Key players are engaged in receiving approval for their products from the regulatory authorities. This is expected to drive growth of the market over the forecast period. For instance, in October 2018, Amneal Pharmaceuticals, Inc., an American biopharmaceutical company announced that a generic version of Onfi (clobazam) tablets, 10 mg and 20 mg for oral use, CIV, and Onfi (clobazam) oral suspension, 2.5 mg/mL, CIV, has been approved by the U.S. Food and Drugs Administration.

Key features of the study:

• This report provides an in-depth analysis of the global benzodiazepine drugs market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global benzodiazepine drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include F.Hoffmann-La Roche Ltd., Torrent Pharmaceuticals Ltd., Mallinckrodt Pharmaceuticals, Pfizer Inc., Viatris Inc. (Mylan N.V.), Labiana Pharmaceuticals, Bausch Health Companies, Inc., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Par Pharmaceutical, and Intas Pharmaceuticals Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global benzodiazepine drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global benzodiazepine drugs market

Detailed Segmentation:

• Global Benzodiazepine Drugs Market, By Product:
  • Long Acting Benzodiazepine
  • Chlordiazepoxide
  • Diazepam
  • Lorazepam
  • Alprazolam
  • Clonazepam
  • Others
  • Short Acting Benzodiazepine
  • Temazepam
  • Midazolam
  • Triazolam
  • Others
• Global Benzodiazepine Drugs Market, By Application:
  • Anxiety Disorders
  • Nervousness
  • Sedation
  • Seizures
  • Alcohol Withdrawal
  • Others
• Global Benzodiazepine Drugs Market, By Route of Administration:
  • Oral
  • Injectables
  • Others
• Global Benzodiazepine Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Benzodiazepine Drugs Market, By Region:
  • North America
• By Product:
  • Long Acting Benzodiazepine
    • Chlordiazepoxide
    • Diazepam
    • Lorazepam
    • Alprazolam
    • Clonazepam
    • Others
  • Short Acting Benzodiazepine
    • Temazepam
    • Midazolam
    • Triazolam
    • Others
• By Application:
  • Anxiety Disorders
  • Nervousness
  • Sedation
  • Seizures
  • Alcohol Withdrawal
  • Others
• By Route of Administration:
  • Oral
  • Injectables
  • Others
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Country:
  • U.S.
  • Canada
  • Latin America
• By Product:
  • Long Acting Benzodiazepine
    • Chlordiazepoxide
    • Diazepam
    • Lorazepam
    • Alprazolam
    • Clonazepam
    • Others
  • Short Acting Benzodiazepine
    • Temazepam
    • Midazolam
    • Triazolam
    • Others
• By Application:
  • Anxiety Disorders
  • Nervousness
  • Sedation
  • Seizures
  • Alcohol Withdrawal
  • Others
• By Route of Administration:
  • Oral
  • Injectables
  • Others
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • ICU's
• By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
• By Product:
  • Long Acting Benzodiazepine
    • Chlordiazepoxide
    • Diazepam
    • Lorazepam
    • Alprazolam
    • Clonazepam
    • Others
  • Short Acting Benzodiazepine
    • Temazepam
    • Midazolam
    • Triazolam
    • Others
• By Application:
  • Anxiety Disorders
  • Nervousness
  • Sedation
  • Seizures
  • Alcohol Withdrawal
  • Others
• By Route of Administration:
  • Oral
  • Injectables
  • Others
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
• By Product:
  • Long Acting Benzodiazepine
    • Chlordiazepoxide
    • Diazepam
    • Lorazepam
    • Alprazolam
    • Clonazepam
    • Others
  • Short Acting Benzodiazepine
    • Temazepam
    • Midazolam
    • Triazolam
    • Others
• By Application:
  • Anxiety Disorders
  • Nervousness
  • Sedation
  • Seizures
  • Alcohol Withdrawal
  • Others
• By Route of Administration:
  • Oral
  • Injectables
  • Others
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Middle East
• By Product:
  • Long Acting Benzodiazepine
    • Chlordiazepoxide
    • Diazepam
    • Lorazepam
    • Alprazolam
    • Clonazepam
    • Others
  • Short Acting Benzodiazepine
    • Temazepam
    • Midazolam
    • Triazolam
    • Others
• By Application:
  • Anxiety Disorders
  • Nervousness
  • Sedation
  • Seizures
  • Alcohol Withdrawal
  • Others
• By Route of Administration:
  • Oral
  • Injectables
  • Others
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
• By Product:
  • Long Acting Benzodiazepine
    • Chlordiazepoxide
    • Diazepam
    • Lorazepam
    • Alprazolam
    • Clonazepam
    • Others
  • Short Acting Benzodiazepine
    • Temazepam
    • Midazolam
    • Triazolam
    • Others
• By Application:
  • Anxiety Disorders
  • Nervousness
  • Sedation
  • Seizures
  • Alcohol Withdrawal
  • Others
• By Route of Administration:
  • Oral
  • Injectables
  • Others
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
• F.Hoffmann-La Roche Ltd.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
• Torrent Pharmaceuticals Ltd.
• Mallinckrodt Pharmaceuticals
• Pfizer Inc.
• Viatris Inc. (Mylan N.V.)
• Labiana Pharmaceuticals
• Bausch Health Companies, Inc.
• Teva Pharmaceutical Industries Ltd.,
• Amneal Pharmaceuticals LLC
• Sun Pharmaceutical Industries Ltd.
• Aurobindo Pharma
• Par Pharmaceutical
• Intas Pharmaceuticals Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product
  • Market Snippet, By Application
  • Market Snippet, By Route of Administration
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Regulatory Scenario
• PEST Analysis
• Recent Product Launch/Approval
• Epidemiology
• Mergers and Acquisitions

4. COVID - 19 Impact Analysis

• Impact on Supply Chain
• Impact on Research and Development
• Government Initiatives

5. Global Benzodiazepine Drugs Market, By Product, 2017-2030 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Long Acting Benzodiazepines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Chlordiazepoxide
  • Diazepam
  • Lorazepam
  • Alprazolam
  • Clonazepam
  • Others
• Short Acting Benzodiazepines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Temazepam
  • Midazolam
  • Triazolam
  • Others

6. Global Benzodiazepine Drugs Market, By Route of Administration, 2017 - 2030 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Anxiety Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Nervousness
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Sedation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Seizures
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Alcohol Withdrawal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

7. Global Benzodiazepine Drugs Market, By Route of Administration, 2017 - 2030 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Injectables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

8. Global Benzodiazepine Drugs Market, By Distribution Channel, 2017 - 2030 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

9. Global Benzodiazepine Drugs Market, By Region, 2017 - 2030 (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018 - 2030
  • Regional Trends
• North America
  • Market Size and Forecast, By Product, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • U.S.
  • Canada
• Latin America
  • Market Size and Forecast, By Product, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Market Size and Forecast, By Product, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Product, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Product, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Market Size and Forecast, By Product, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2017 - 2030 (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

10. Competitive Landscape

• Company Profiles
  • F.Hoffmann-La Roche Ltd.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Torrent Pharmaceuticals Ltd.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Mallinckrodt Pharmaceuticals
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Pfizer Inc.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Viatris Inc. (Mylan N.V.)
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Labiana Pharmaceuticals
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Bausch Health Companies, Inc.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Amneal Pharmaceuticals LLC
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Aurobindo Pharma
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Par Pharmaceutical
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Intas Pharmaceuticals Ltd.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
• Analyst Views

11. Section

• References
• Research Methodology
• About us and Sales Contact